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Fetuses that are small for gestational age (SGA) are at increased 
risk of stillbirth. SGA fetuses that are not detected during the 
antepartum period are at a four-fold increased risk of serious fetal 
complications compared with SGA fetuses detected before delivery. [1] 
It is therefore important to identify SGA pregnancies antenatally 
so that complications and stillbirth risk can be reduced through 
appropriate monitoring and clinical care.
Traditionally, country-specific population fetal growth charts have 
been used to identify SGA infants. However, there is substantial 
intercountry variation between growth charts, meaning that a fetus 
whose growth is tracking as appropriate using one particular chart may 
be classified as growth restricted under another.[2] Recently a global, 
multiethnic standardised chart for fetal growth and size was developed 
by the International Fetal and Newborn Growth Consortium for the 
21st Century (INTERGROWTH-21st).[3,4] INTERGROWTH-21st is 
intended for global use and improves comparison between countries. [5] 
It has been advocated that this new standard should be adopted by 
professional bodies,[5] but uptake has been variable to date. The ability 
of INTERGROWTH-21st to identify SGA in stillbirth cases compared 
with local South African (SA) standards (Theron-Thompson growth 
charts) has not been assessed.
Studies comparing local growth standards with INTERGROWTH-
21st have mainly been conducted in high-resource countries such 
as New Zealand (NZ) and the UK.[6,7] These studies have shown that 
INTERGROWTH-21st underestimated SGA in at-risk infants in 
NZ[6] and stillbirths in the UK[7] compared with local standards. The 
NZ study showed that INTERGROWTH-21st was specifically less 
able to detect at-risk SGA infants compared with local customised 
standards among some ethnic groups, including Maori, European 
and Pacific women.[6] In a middle-income setting, a Chinese study 
found that INTERGROWTH-21st overestimated the proportion 
of SGA liveborn infants compared with local standards, resulting 
in an increase in the number of pregnancies requiring further 
investigations to ascertain fetal wellbeing.[8]
The variation observed in classifying at-risk SGA infants 
using INTERGROWTH-21st growth standards, in particular 
for different ethnicities,[6] suggests that investigation to compare 
INTERGROWTH-21st with local Theron-Thompson standards in 
the SA population of stillbirths is warranted. Further, there is limited 
published literature on the impact of gestational age on the agreement 
of INTERGROWTH-21st and local fetal growth charts in identifying 
SGA infants.
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Background. Global growth standards for fetuses were recently developed (INTERGROWTH-21st). It has been advocated that professional 
bodies should adopt these global standards.
Objectives. To compare the ability of INTERGROWTH-21st with local standards (Theron-Thompson) to identify small-for-gestational-age 
(SGA) fetuses in stillbirths in the South African (SA) setting.
Methods. Stillbirths across SA were investigated (>500 g, 28 - 40 weeks) between October 2013 and December 2016 (N=14 776). The study 
applied the INTERGROWTH-21st standards to classify stillbirths as <10th centile (SGA) compared with Theron-Thompson growth charts, 
across pregnancy overall and at specific gestational ages.
Results. The prevalence of SGA was estimated at 32.2% and 31.1% by INTERGROWTH-21st and Theron-Thompson, respectively. 
INTERGROWTH-21st captured 13.8% more stillbirths as SGA in the earlier gestations (28 - 30 weeks, p<0.001), but 4.0% (n=315) fewer 
between 33 and 38 weeks (p<0.001). Observed agreement and the Kappa coefficient were lower at earlier gestations and at 34 - 36 weeks.
Conclusions. Our findings demonstrated differences in the proportion of stillbirths considered SGA at each gestational age between the 
INTERGROWTH-21st and the local SA standard, which have not been considered previously by other studies.
S Afr Med J 2019;109(7):519-525. DOI:10.7196/SAMJ.2019.v109i7.13485
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Objectives
The primary objective of this study was to determine the proportion 
of stillbirths classified as SGA using INTERGROWTH-21st compared 
with local Theron-Thompson growth charts. The study allowed for 
comparison of the proportion of stillbirths classified as SGA in the 
SA population with global estimates for the first time. The secondary 
objective was to determine whether there were differences in the 
proportion of stillbirths identified as SGA by gestational age.
Methods
A secondary analysis of all stillbirths across SA (>500 g and 
≥28  weeks ≤40 weeks) between October 2013 and December 2016 
was conducted. The SA Perinatal Problems Identification Program 
(PPIP) database was used for this study, capturing >90% of deaths 
across all health facility levels in SA. PPIP is a perinatal quality audit 
system that has been described in detail elsewhere.[9] Briefly, after 
each perinatal death the clinical team performs a review and records 
clinical information around the cause of death as well as weight/
gestational age. Gestational age is determined based on the date of 
the last menstrual period (LMP), ultrasound or clinical examination. 
Stillbirths are classified as macerated, which are clinically diagnosed 
when the skin of the fetus is discoloured, blotchy and friable to touch, 
or as fresh when the skin is intact and ‘normal’ in appearance.
Data were extracted in aggregate form at health facility level. 
Stillbirth cases were excluded if the gestational age was unknown 
(n=20 786, 46.9%) or if the estimated age was considered ‘uncertain’ 
(n=8 750, 19.7%).
Theron-Thompson growth charts
Theron-Thompson growth charts were developed in 1995 using 
an urban population in Western Cape Province, SA (N=3 643). [10] 
It included women who presented antenatally at the Tygerberg 
Hospital obstetric service (including attached community clinics), 
representing half of all women who delivered in the circumscribed 
urban area. The mean age of the group was 25.1 years (range 14  - 
46), 40.6% were primigravidas, and 92.1% were of coloured ethni-
city, 4.3% white, 3.4% black and 0.2% Asian. Gestational age was 
confirmed by early ultrasound. Centile charts for birth weight by 
gestational age were constructed for this population.
Classification as SGA
PPIP automatically classifies cases below the 10th centile using 
Theron-Thompson growth charts as SGA. The classification of 
stillbirths as SGA using INTERGROWTH-21st was performed by 
applying the <10th centile birth-weight cut-off at each gestational 
age.
Statistical analysis
The prevalence of SGA was calculated for the study sample as the 
number of SGA stillbirths divided by the total number of stillbirths 
and presented as a proportion. It was calculated for Theron-
Thompson and INTERGROWTH-21st separately.
Observed agreement for identifying SGA infants using 
INTERGROWTH-21st and Theron-Thompson growth charts was 
calculated. The Kappa coefficient (κ) and 95% confidence intervals 
were calculated for concordance between identification of SGA 
using INTERGROWTH-21st and Theron-Thompson. Observed 
agreement and κ were calculated overall across pregnancy (28 - 
40 weeks) and individually at each gestational age (weeks). This 
was done separately for all stillbirths, macerated stillbirths, fresh 
stillbirths and intrauterine growth-restricted (IUGR) stillbirths.
Pearson’s χ2 test or Fisher’s exact test (where n<5) were used to 
compare the crude proportions of SGA stillbirths between Theron-
Thompson and INTERGROWTH-21st at each gestational age (in 
weeks). Comparisons were made at each gestational age for all 
stillbirths, and separately for macerated and fresh stillbirths. In 
addition, stillbirths with a confirmed primary cause of death as IUGR 
were examined as a separate cohort. We also made comparisons 
between methods of gestational age determination (LMP, ultrasound 
or clinical examination), as well as separate analyses by method of 
gestational age determination. The proportion of SGA stillbirths 
at each gestational age compared between Theron-Thompson and 
INTERGROWTH-21st was tested using Pearson’s χ2 test.
Results
There were 14 776 eligible stillbirths (after exclusion for unknown 
gestational age) during the study period (9 725 macerated, 5 051 
fresh). There were no statistically significant differences between the 
included and excluded cases in terms of maternal age, parity, HIV 
status or syphilis status. There were 9 389 stillbirths (63.5%) not 
classified as SGA using any criteria. A total of 30.1% of stillbirths 
(n=4 452) were classified as SGA using both criteria, 3.2% (n=465) 
were identified by INTERGROWTH-21st only and 2.1% (n=315) 
were identified by Theron-Thompson only; 1.1% (n=155) were 
classified as appropriate for gestational age (AGA) by Theron-
Thompson only.
Sociodemographic characteristics
Clinical characteristics of the study cohort are presented in Table 1. 
Compared with stillbirths that were classified as SGA (both criteria), 
mothers in the group classified as AGA (using both criteria) were 
healthier and more frequently primiparous and included fewer HIV-
positive cases and fewer preterm births. The SGA INTERGROWTH-
Table 1. Clinical characteristics of SGA stillbirth cases by method of classification, SA, October 2013 - December 2016 (N=14 776)
 
All stillbirths 
(N=14 776), n (%)
SGA INTERGROWTH-
21st only (N=465), 
n (%)
SGA Theron-
Thompson only 
(N=325), n (%)
Both SGA† 
(N=4 452), n (%)
AGA‡ (N=9 389), 
n (%)
AGA Theron-
Thompson only 
(N=155), n (%)
‘Healthy’ mother§ 8 182 (55.4) 253 (52.2) 131 (41.5) 2 355 (52.9) 5 239 (55.8) 88 (56.8)
Primipara 6 076 (41.1) 199 (42.8) 125 (38.3) 1 812 (40.7) 3 877 (41.3) 81 (52.3)
Received antenatal care 14 096 (95.4) 436 (93.7)* 304 (96.5) 4 234 (95.1) 8 508 (95.1) 136 (87.7)
HIV (positive) 4 104 (27.7) 193 (41.5)* 86 (27.3) 1 296 (29.1) 2 525 (26.9) 90 (58.1)
Preterm birth 9 530 (64.5) 428 (92.0)* 230 (73.0) 3 103 (69.7) 5 689 (60.5) 95 (61.3)
SGA = small for gestational age; SA = South Africa; AGA = appropriate for gestational age.
*p<0.05 comparing INTERGROWTH-21st with Theron-Thompson only (Pearson’s χ2 test).
†Both criteria identified stillbirth as SGA.
‡Neither criterion identified stillbirth as SGA. Overall across pregnancy there were no stillbirths classified as AGA by INTERGROWTH-21st criteria only (i.e. all fetuses classified as AGA using 
INTERGROWTH-21st were also classified as AGA using Theron-Thompson).
§The clinician examining the mother could not find any clinical problems or maternal conditions.
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21st-only group included more healthy, 
primparous mothers, fewer mothers who 
had received antenatal care, more HIV-
positive mothers and a higher proportion of 
preterm births (Table 1).
Prevalence of SGA
The prevalence of SGA was estimated at 
32.2% (n=4 753) and 31.1% (n=4 598) 
by INTERGROWTH-21st and Theron-
Thompson criteria, respectively (p=0.052). In 
IUGR fetuses (n=384), the incidence of SGA 
was 78.1% (n=300) using INTERGROWTH-
21st and 77.6% (n=298) using Theron-
Thompson (p=0.058).
Observed agreement and κ
Overall across pregnancy, observed agree -
ment between the methods of SGA 
determination was high (98.9%); κ was also 
high at 0.976. Similar results were seen 
for fresh (99.3%, κ 0.982) and macerated 
(98.8%, κ 0.968) stillbirths (Table 2). When 
considering each gestational age separately, 
the lowest observed agreement was at 
lower gestations (28 and 29 weeks 76.4% 
and 86.3%, respectively, and 34 - 36 weeks 
94.6%, 92.5% and 94.7%, respectively). For 
stillbirths with IUGR as a primary cause 
of death, observed agreement was lower at 
28 and 29 weeks (67.7%, 93.3%) and 37 - 
39  weeks (95.5%, 94.1%, 86.7%) compared 
with other gestations. Overall agreement 
across pregnancy was high at 99.5% (κ 0.985) 
for IUGR deaths.
Proportion of SGA stratified by 
gestational age
A comparison of INTERGROWTH-21st 
and Theron-Thompson standards across 
gestation can be seen in Fig. 1. When 
considering each gestational age (weeks) 
separately, there were differences in the 
proportion of SGA fetuses classified as SGA 
between INTERGROWTH-21st and Theron-
Thompson. INTERGROWTH-21st captured 
13.8% (n=437) more stillbirths as SGA in the 
earlier gestations (28 - 30 weeks; p<0.001) 
but 4.0% (n=315) fewer at gestations between 
33 and 38 weeks (p<0.001) compared with 
Theron-Thompson (Fig. 2, A). This trend 
was observed for both macerated and fresh 
stillbirths (Fig. 2, B and C).
In pregnancies with IUGR as a primary 
cause of death, INTERGROWTH-21st 
classified 16.0% more stillbirths as SGA 
at younger gestations (28 - 30 weeks) and 
9.4% fewer at 38 - 39 weeks compared with 
Theron-Thompson (Fig. 3). However, the 
only statistically significant difference was at 
28 weeks (p=0.011). Ta
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Comparison between methods of gestational age 
determination
Gestational age was determined by ultrasound in 37.0% of stillbirths 
and by clinical examination, the LMP or both in 63.0%. When using 
Theron-Thompson standards to identify SGA infants, ultrasound 
classified a larger proportion of stillbirths as SGA (34.0%) than 
clinical examination or the LMP (29.2%) (p<0.001). The level of 
agreement for identifying SGA differed by gestational age between 
INTERGROWTH-21st and Theron-Thompson depending on the 
method used (ultrasound v. clinical examination/LMP) (Table 3). 
The LMP/clinical examination group had slightly higher levels of 
agreement between the charts than ultrasound (99.2% v. 98.3%, 
respectively). The lowest levels of agreement between the charts were 
at 28 weeks (ultrasound 74.8%, clinical examination/LMP 77.2%).
Discussion
This large national study found the proportion of stillbirths classified 
as SGA to be similar between INTERGROWTH-21st and local 
Theron-Thompson growth charts. Overall across pregnancy, 
observed agreement and concordance were high. However, when 
considering gestational age, INTERGROWTH-21st classified more 
SGA stillbirths at younger gestations and fewer at later gestations 
compared with Theron-Thompson. A similar trend was observed 
for IUGR-specific stillbirths. Observed agreement and κ varied at 
each gestational age, with lower agreement at lower gestations and 
at 34 - 36 weeks.
Proportion of SGA compared with other populations
One of the aims of INTERGROWTH-21st was that it would enable 
comparisons in fetal growth and SGA between different settings 
using a standardised chart. This is the first empirical comparison 
between the proportion of stillbirths that are SGA in our population 
and those in other settings using a standardised classification system. 
The overall proportion of stillbirths that were SGA in our study was 
similar to that of a UK study (32.6%).[7] In the UK and NZ, it has been 
reported that INTERGROWTH-21st underestimated SGA in at-risk 
infants[6] and stillbirths[7] compared with local standards. When 
considering the proportion of SGA stillbirths at a population level, 
we did not observe any significant under- or overestimation of SGA 
by INTERGROWTH-21st in the current study.
In the current study, there were no significant differences in 
the overall proportion of stillbirths classified as SGA between the 
INTERGROWTH-21st and local methods, and overall observed 
agreement and κ were high. In studies where gestational age is not an 
important factor and overall SGA prevalence across pregnancy is the 
outcome of interest, INTERGROWTH-21st may offer a standardised 
method of comparison between populations, such as in multicountry 
studies.
SGA by gestational age
This is the first study to explore the application of INTER GROWTH-
21st to local growth curves at each gestational age. INTERGROWTH-
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21st classified more SGA stillbirths at earlier gestations and fewer at 
later gestations. Observed agreement and concordance were also 
lower at these gestations. The largest discrepancies for 10th-centile 
cut-points between the two charts were at the younger gestations. 
At these gestations, INTERGROWTH-21st identified a much larger 
proportion of SGA stillbirths than Theron-Thompson. Previous 
studies have not considered the impact of gestational age on observed 
agreement for different methods of SGA identification. In the current 
study, this observation would have been masked if comparisons were 
only made overall across pregnancy, indicating the importance of 
assessment by specific gestational age.
The reasons for the differences between classification by 
INTERGROWTH-21st and Theron-Thompson at different gestations 
are unclear, but ethnicity, population-specific growth differences and 
inaccuracies in gestational age/weight may all play a role.
Differences in the composition of ethnicities in the samples 
used to develop Theron-Thompson and INTERGROWTH-21st 
may contribute to the differences seen in the fetal growth charts in 
identifying SGA. INTERGROWTH-21st was based on women from 
eight countries aged 15 - 35 years, with no diagnosed morbidity, 
who were well nourished, lived in urban areas and did not smoke.[11] 
The premise was that these women were ‘low-risk’ healthy women 
who represented ‘normal physiological growth’ and comprised a 
multiethnic sample.[11] SA also has a multiethnic population with 
more than 10 ethnic groups, none of which were included in 
the development of INTERGROWTH-21st. Several studies have 
observed ethnic differences in the application of INTERGROWTH-
21st. An NZ study found that compared with INTERGROWTH-21st, 
customised criteria identified 2 - 3 times as many SGA infants in 
Maori, Pacific, European and Asian pregnancies.[6] The National 
Institute of Child Health and Human Development fetal growth 
studies found significant differences in fetal growth by race/ethnicity 
in US women and has since developed race-specific charts.[12] It 
is possible that racial/ethnic differences in fetal growth across 
pregnancy are present and may account for the differences seen at 
specific gestational ages.
The differences observed may also extend to a population level. 
There are recognised differences in optimal perinatal outcome 
achieved at different birth weights in different populations.[13,14] 
Different populations have different birth-weight distributions 
and optimal fetal growth standards as well as perinatal mortality 
curves. [13,14] The mortality curves are shifted in the same direction 
as birth weight.[13] The findings of the current study also support the 
notion that differences in fetal growth patterns resulting in adverse 
outcome (stillbirth) are present when using population-specific 
growth charts as opposed to internationally derived charts.
A possible alternative explanation for differences across gestational 
age is that there are greater inaccuracies in the determination 
of gestational age and weight at younger gestations, leading to 
higher levels of disagreement between INTERGROWTH-21st and 
Theron-Thompson (larger differences at smaller gestations). Using 
ultrasound to determine intrauterine estimates of fetal weight is 
known to be less accurate at <2 000 g,[15] and symphysis-fundal height 
and the LMP have known inherent issues in determining gestational 
age and size.[16] We sought to reduce these issues by including only 
cases in which gestational age determination was ‘certain’. One would 
expect that symphysis-fundal height/LMP would have a greater 
number of inaccuracies in determining gestational age and more 
difficulty in determining fetal weight given small fetal size. However, 
this was not reflected in our data, with greater agreement between the 
charts for gestational age determined by LMP/clinical examination at 
most gestations. We also had a large sample size (>1 900 stillbirths) 
at gestations of 28 - 29 weeks, therefore not compromising the power. 
Overall it is unlikely that the differences seen at earlier gestations are 
an artefact of inaccuracies in gestational age or weight determination 
at younger gestations.
Public health implications
If INTERGROWTH-21st charts were to be adopted clinically in 
SA as a method to identify ‘high-risk’ women based on fetal 
growth, this would have implications for maternal health service 
systems. Women in SA receive antenatal care at the community 
level with a nurse/midwife and are up-referred to obstetric specialist 
care at the district level if identified as high risk.[17] One of the 
criteria for high risk is SGA and/or slowing growth velocity as 
classified through growth charts. Specialised obstetric care and 
serial ultrasound are only available in high-risk pregnancies. The 
adoption of INTERGROWTH-21st would increase the number 
Table 3. Observed agreement and kappa coefficient for method of gestational age determination (ultrasound and clinical 
examination/LMP), SA, October 2013 - December 2016
Ultrasound Clinical examination/LMP
Gestation (weeks) Observed agreement, % κ (95% CI) Observed agreement, % κ (95% CI)
Overall (28 - 40) 98.3 0.961 (0.954 - 0.969) 99.2 0.982 (0.978 - 0.986)
28 74.8 0.433 (0.366 - 0.499) 77.2 0.418 (0.357 - 0.479)
29 85.6 0.696 (0.627 - 0.764) 87.1 0.033 (0.659 - 0.788)
30 94.4 0.874 (0.829 - 0.919) 96.7 0.916 (0.884 - 0.948)
31 98.9 0.975 (0.95 - 0.999) 99.3 0.986 (0.969 - 1.000)
32 99.0 0.978 (0.96 - 0.995) 99.0 0.987 (0.976 - 0.997)
33 95.5 0.908 (0.867 - 0.950) 98.1 0.958 (0.932 - 0.984)
34 93.7 0.872 (0.827 - 0.917) 95.3 0.903 (0.873 - 0.933)
35 92.9 0.850 (0.797 - 0.903) 92.5 0.841 (0.797 - 0.885)
36 94.3 0.883 (0.842 - 0.923) 95.4 0.895 (0.867 - 0.923)
37 97.3 0.936 (0.904 - 0.969) 98.6 0.963 (0.945 - 0.982)
38 97.0 0.929 (0.896 - 0.962) 96.9 0.909 (0.884 - 0.934)
39 99.7 0.993 (0.98 - 1.000) 99.5 0.987 (0.975 - 1.000)
40 95.8 0.904 (0.851 - 0.957) 96.3 0.899 (0.861 - 0.938)
LMP = last menstrual period; SA = South Africa; CI = confidence interval.
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of women classified as high risk and up-referred for obstetric 
antenatal at lower gestations (28 - 30 weeks), increasing demand on 
already under-resourced obstetric services. Increased medicalisation 
without prevention of adverse perinatal outcomes due to suboptimal 
diagnostic accuracy of antenatal growth charts has been highlighted 
previously.[3] It is unclear whether identifying more pregnancies as 
SGA at earlier gestations would result in a decrease in stillbirths or 
increased medicalisation without prevention of adverse outcomes.
Conversely, based on our findings, the application of 
INTERGROWTH-21st classification to the SA population would 
decrease the proportion of women classified as high risk due to 
SGA at gestations of 34 - 36 weeks. This gestational period has been 
identified as a crucial period for stillbirths in SA,[9] and has also 
been identified as a high-risk period for women who do not receive 
antenatal care during this time.[18] It is possible that not recognising 
these pregnancies as SGA and therefore continuing to consider them 
as low risk would result in an increased stillbirth rate during this 
period. Further, the timing of ultrasound assessment (only available 
to high-risk women in SA) for SGA in late pregnancies becomes 
important owing to the slowing of growth velocity of some fetuses 
near term, thus meeting the criteria for SGA for the first time in late 
pregnancy.[19] An increased number of these fetuses may be missed 
if a less sensitive INTERGROWTH-21st growth chart is used at this 
time point.
From a public health perspective, an optimal fetal growth standard 
is one that most accurately identifies fetuses at risk of poor perinatal 
outcome.[13] Population-specific growth standards and customised 
growth charts are arguably more appropriate than generalised growth 
standards owing to their ability to take into account the fact that 
optimal perinatal outcomes are achieved at different birth weights for 
different populations. The current study observed differences in the 
population-specific charts in recognising SGA fetuses where adverse 
outcomes occurred (all stillbirths and IUGR stillbirths) compared 
with international standards at different gestational ages. The impact 
of the differences by gestational age on adverse perinatal outcomes 
would need to be considered if SA were to adopt INTERGROWTH-
21st in place of local standards as a method of classifying SGA 
pregnancies. Currently, customised growth charts based on an SA 
population are not available.
Study strengths and limitations
While it is important to identify SGA fetuses, it must also be 
recognised that growth charts only identify pregnancies requiring 
further investigation. A fetus that is classified as SGA may not 
necessarily be pathologically growth restricted, and may be healthy 
with normal growth that just happens to fall in the lowest 10th centile 
on growth charts.[20] In addition, it must be acknowledged that growth 
restriction may also occur in AGA pregnancies.[21] This was observed 
in our study, where one-fifth of stillbirths with IUGR as the primary 
cause of death were AGA (using either growth chart). Umbilical 
artery Doppler measurements using an inexpensive hand-held device 
such as the Umbiflow can be used to identify such cases.[21]
This study focused on stillbirths only, representing pathological 
pregnancies. It is likely that SGA estimates for macerated stillbirths 
are overestimated using all criteria, as the death may have occurred 
up to 3 weeks earlier[22] and the fetus may therefore have been AGA 
at the time of death. Fresh stillbirths are likely to represent more 
accurate estimates for SGA, as the time difference between fetal death 
and delivery is not considerable. Future studies should consider the 
prevalence of SGA in live births to reduce the overestimation of SGA. 
We were also only able to examine pregnancies at 28 - 40 weeks, 
as Theron-Thompson growth charts are not reliable for gestations 
<28  weeks[10] and INTERGROWTH-21st estimated fetal weight is 
only available up to 40 weeks.
This was one of the largest studies in low- to middle-income 
countries (LMICs) examining the proportion of SGA stillbirths 
using INTERGROWTH-21st standards. It is unclear how these 
results can be generalised to other LMICs owing to differences in 
ethnicity and fetal growth at a population level, which may influence 
the classification of SGA in stillbirths.[6,12] The study has highlighted 
the need for each country to carefully examine and consider the 
application of INTERGROWTH-21st in its own context, specifically 
at each gestational age, before  adopting these standards for clinical 
use or use in epidemiology.
Conclusions
Our study showed differences in the estimated proportion of 
stillbirths considered SGA at each gestational age, depending on 
the growth chart used, that have not been considered in previous 
studies. This finding highlights the importance of future studies 
considering SGA at each gestational age and not simply comparing 
proportions across the entire pregnancy period. The development 
of an international standard is essential to compare the prevalence 
of SGA between countries. The results of the current study have 
public health implications for identifying infants at risk of stillbirth 
antenatally in a low-resource setting. Each country must carefully 
consider the impact of using INTERGROWTH-21st owing to the 
issues raised in this study pertaining to gestational age and potential 
ethnic and population differences in optimal fetal growth.
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